PTC Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 58 U.S.-traded ETFs. PTCT has around 7.4M shares in the U.S. ETF market. The largest ETF holder of PTCT is the iShares Russell 2000 ETF (IWM), with approximately 1.56M shares. Investors may also find of interest that the ETF with the largest allocation to PTCT stock is iShares Neuroscience and Healthcare ETF (IBRN), with a portfolio weight of 3.85%. On average, U.S. ETFs allocate 0.41% of PTCT to their portfolios.
Additionally, PTCT is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with PTCT as a holding is the Avantis Responsible U.S. Equity ETF (AVSU), with a return of --.